Browsing Tag
INTASYL
2 posts
Investors eye PHIO as Phio Pharmaceuticals reports full Phase 1b enrollment and strong preliminary PH-762 results
Find out how Phio Pharmaceuticals’ PH-762 trial progress and early response signals could reshape RNA-based cancer therapies.
Phio’s INTASYL therapy PH-762 shows 100% tumor clearance in skin cancer dose-escalation study
Find out how Phio Pharmaceuticals’ RNAi-based PH-762 achieved high tumor clearance in a skin cancer study and what it could mean for non-surgical treatment paths today!